Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.

Rogers MS, Cryan LM, Habeshian KA, Bazinet L, Caldwell TP, Ackroyd PC, Christensen KA.

PLoS One. 2012;7(6):e39911. doi: 10.1371/journal.pone.0039911. Epub 2012 Jun 29.

2.

Interactions between anthrax toxin receptors and protective antigen.

Scobie HM, Young JA.

Curr Opin Microbiol. 2005 Feb;8(1):106-12. Review.

PMID:
15694864
3.

The dark sides of capillary morphogenesis gene 2.

Deuquet J, Lausch E, Superti-Furga A, van der Goot FG.

EMBO J. 2012 Jan 4;31(1):3-13. doi: 10.1038/emboj.2011.442. Epub 2011 Dec 6. Review.

4.

Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.

Cryan LM, Rogers MS.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1574-88. Review.

5.

LRP6 holds the key to the entry of anthrax toxin.

Bann JG, Cegelski L, Hultgren SJ.

Cell. 2006 Mar 24;124(6):1119-21. Review.

6.

Anthrax toxin receptor proteins.

Bradley KA, Young JA.

Biochem Pharmacol. 2003 Feb 1;65(3):309-14. Review.

PMID:
12527323
7.

Anti-infective immunoadhesins from plants.

Wycoff K, Maclean J, Belle A, Yu L, Tran Y, Roy C, Hayden F.

Plant Biotechnol J. 2015 Oct;13(8):1078-93. doi: 10.1111/pbi.12441. Epub 2015 Aug 4. Review.

Items per page

Supplemental Content

Write to the Help Desk